Have your own idea? Try our Stock Screener
UPDATED May 08, 2025
Discover Indian Pharmaceuticals & Biotech High Yield Dividend Stocks that are on the NIFTY and sorted by Dividend Yield. An upper limit of 20% is in place to filter out stocks with potentially unsustainable dividends. All companies with high dividend yields (above 5%) should be researched for sustainability. For more options please click on ‘Advanced Filters’.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
524394 | ₹948.90 | -6.8% | 93.9% | ₹21.1b | n/a | PE38.6x | n/a | 0.2% | ||
SYNGENE | ₹614.10 | -2.2% | -7.9% | ₹246.7b | ₹746.50 | PE49.7x | E14.4% | 0.2% | ||
539872 | ₹517.80 | 0.3% | 70.0% | ₹16.4b | n/a | PS3.1x | n/a | 0.2% | ||
JSLL | ₹2,178.35 | 0.9% | 104.8% | ₹54.2b | n/a | PE64.3x | n/a | 0.2% | ||
GLENMARK | ₹1,398.20 | 1.7% | 36.5% | ₹394.6b | ₹1,690.92 | PS2.8x | E63.1% | 0.2% | ||
SMSPHARMA | ₹238.06 | -0.5% | 16.8% | ₹21.1b | n/a | PE31.9x | n/a | 0.2% | ||
524774 | ₹1,127.85 | 1.0% | -53.0% | ₹7.0b | n/a | PE21.4x | n/a | 0.2% | ||
BIOCON | ₹329.90 | 3.4% | 8.5% | ₹394.8b | ₹379.70 | PE49.1x | E24.0% | 0.2% | ||
BLUEJET | ₹725.65 | 0.3% | 90.9% | ₹125.9b | ₹855.83 | PE53.6x | E22.2% | 0.1% | ||
AMIORG | ₹1,161.10 | -0.06% | 92.4% | ₹95.1b | ₹1,356.25 | PE59.9x | E25.0% | 0.1% | ||
SUPRIYA | ₹629.00 | -1.5% | 66.3% | ₹50.6b | ₹740.00 | PE29x | E11.5% | 0.1% | ||
ZOTA | ₹822.75 | -7.7% | 73.4% | ₹20.7b | n/a | PS8.4x | n/a | 0.1% | ||
SMSLIFE | ₹1,262.20 | -7.0% | 94.5% | ₹3.8b | n/a | PE16.6x | n/a | 0.1% | ||
524558 | ₹12,434.70 | 4.1% | 74.3% | ₹159.5b | ₹17,600.00 | PE53.2x | E33.3% | 0.1% | ||
539730 | ₹692.85 | -1.2% | -18.9% | ₹3.3b | n/a | PE17.3x | n/a | 0.1% | ||
541096 | ₹1,089.30 | 10.3% | -30.1% | ₹7.1b | n/a | PS2.3x | n/a | 0.09% | ||
PPLPHARMA | ₹207.77 | -1.5% | 38.1% | ₹275.5b | ₹296.00 | PE708.1x | E66.4% | 0.05% | ||
509079 | ₹355.00 | -1.5% | 9.8% | ₹35.6b | n/a | PE43.4x | n/a | 0.03% | ||
VIVIMEDLAB | ₹4.95 | 0% | -45.9% | ₹410.4m | n/a | PB1x | n/a | 0% | ||
SUVENPHAR | ₹1,077.80 | -5.1% | 67.4% | ₹274.4b | ₹1,396.67 | PE98.3x | E38.9% | 0% | ||
ERIS | ₹1,456.00 | -2.5% | 70.0% | ₹198.3b | ₹1,512.56 | PE60.2x | E35.3% | 0% | ||
540737 | ₹724.45 | -1.2% | 22.4% | ₹9.3b | n/a | PE32.7x | n/a | 0% | ||
524790 | ₹416.35 | 3.5% | 234.8% | ₹4.0b | n/a | PS2.4x | n/a | 0% | ||
PAR | ₹97.80 | -6.0% | -62.0% | ₹1.2b | n/a | PE7.8x | n/a | 0% |